Results 201 to 210 of about 269,233 (300)

Association of Growth Hormone Adherence and Growth Outcomes in Paediatric Patients: Results From a Clinical Registry

open access: yesClinical Endocrinology, Volume 104, Issue 6, Page 603-611, June 2026.
ABSTRACT Objective Daily growth hormone (GH) therapy for growth disorders requires long‐term adherence. The aim of this study was to investigate the association of adherence with 2‐year growth outcomes in paediatric patients receiving daily GH therapy in a clinical registry. Design Retrospective cohort study. Patients Patients with growth disorder were
Tilman Robert Rohrer   +5 more
wiley   +1 more source

Significance of Smelling Across the Lifespan (SoSAL)

open access: yesJournal of Sensory Studies, Volume 41, Issue 3, June 2026.
ABSTRACT The significance of olfaction in human behavior is well recognized, yet there is a lack of standardized measurement tools applicable to all age groups. Particularly, children and the elderly currently lack specific standardized assessment instruments.
Shubin Li   +5 more
wiley   +1 more source

Resolved HBV Infection Is Not Associated With Liver‐Related Outcomes in Survival Analysis of Caucasians After HCV Cure

open access: yesLiver International, Volume 46, Issue 6, June 2026.
ABSTRACT Background Previous exposure to hepatitis B virus (HBV) may influence the risk of developing hepatocellular carcinoma (HCC) and other liver‐related events (LRE), in particular in patients after HCV cure. Previous studies were not conclusive and there are only few large studies on this topic from Europe. Methods We analysed clinical endpoints (≥
Laura Muana Wilhelm   +10 more
wiley   +1 more source

Molecular epidemiology of multidrug-resistant organisms on mobile phones: an observational study conducted at a German university hospital. [PDF]

open access: yesAntimicrob Resist Infect Control
Hack D   +5 more
europepmc   +1 more source

Treatment landscape from first‐ to third‐line therapy and quality of life data of patients with pancreatic cancer from the prospective German PARAGON (Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer) registry (IKF‐PARAGON study)

open access: yesInternational Journal of Cancer, Volume 158, Issue 10, Page 2560-2570, 15 May 2026.
What's New? Pancreatic cancer often is diagnosed at advanced stages. As a result, treatment regimens frequently are aggressive, with substantial side effects that impact quality of life (QoL). This study examined the treatment landscape, from neoadjuvant therapy to palliative care, in the context of QoL among pancreatic cancer patients in Germany. Most
Thorsten O. Goetze   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy